Mechanism of Shenyuan Yiqi Huoxue capsule alleviating coronary microvascular dysfunction: network analysis and experimental evidence
SYYQ improves CMD by promoting the production of angiogenic factors and inhibiting apoptosis via miR-302a-3p/Hippo.
Authors
- Jiaping Chen (ORCID: https://orcid.org/0000-0002-5240-0757)
- Huiwen Zhou (ORCID: https://orcid.org/0000-0003-4793-5068)
- Yuxin Shi (ORCID: https://orcid.org/0009-0007-3800-9122)
- Xiang Li (ORCID: https://orcid.org/0000-0003-0356-4066)
- Shuwen Zhang (ORCID: https://orcid.org/0000-0002-5969-1737)
- Yunze Li (ORCID: https://orcid.org/0000-0001-9269-5644)
- Hongxu Liu (ORCID: https://orcid.org/0000-0002-2899-8605)
- Huiqi Zong
Institutions
- Capital Medical University (CN)
- Jining Traditional Chinese Medicine Hospital (CN)
- Hangzhou Hospital of Traditional Chinese Medicine (CN)
- Beijing Hospital of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-08-04
- DOI
- https://doi.org/10.3389/fphar.2025.1534967
- Citations
- 1
- Primary Topic
- Hippo pathway signaling and YAP/TAZ
- Type
- article
- Field-Weighted Citation Impact
- 1.15
Funders
- National Natural Science Foundation of China
- Beijing University of Chinese Medicine
- Natural Science Foundation of Tibet Autonomous Region